Expanded Access to Telisotuzumab Vedotin
NCT04830202
·
clinicaltrials.gov ↗
TEMPORARILY_NOT_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Non-Small Cell Lung Cancer (NSCLC)
Interventions
DRUG:
Telisotuzumab vedotin
Sponsor
AbbVie